Status:
RECRUITING
Immune Cells in Diabetic Chronic Foot Ulcers
Lead Sponsor:
Karolinska Institutet
Conditions:
Diabetic Foot
Immune Defect
Eligibility:
All Genders
18-98 years
Brief Summary
The goal of this observational study is to learn about the role of immune cells in patients with diabetes and chronic foot ulcers. Researchers will compare blood and tissue samples of patients with di...
Detailed Description
Diabetic foot ulcer (DFU) requires frequent hospital visits, anti-biotic therapies, and surgical procedures. Not only this approach has debilitating consequences for patients and enormous costs for th...
Eligibility Criteria
Inclusion
- diabetes with diabetic foot ulcer
Exclusion
- impaired cognitive function
- on-going immune suppressive treatment
- diagnosed active cancer
- cancer treatment
- known chronic inflammatory disease
Key Trial Info
Start Date :
September 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06154915
Start Date
September 9 2022
End Date
December 31 2029
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Huddinge, Stockholm County, Sweden, 141 57